CALCIMIMETIC ADHERENCE AND PREFERENCE IN THE MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN EUROPE: A PILOT STUDY

被引：0
|
作者：
Louie, Karly [1 ]
Nduka, Chidozie [1 ]
Taylor, Jo [2 ]
Hall, Matthew [3 ]
Aucella, Filippo [4 ]
Artero, Josep [5 ]
Na, Pablo Ure [6 ]
Labriola, Laura [7 ]
Andersson, Per-Olof [8 ]
Evenepoel, Pieter [9 ]
Oliva, Juan Carlos Gonzalez [10 ]
Pisoni, Ronald [11 ]
Fouqueray, Bruno [12 ]
Horne, Robert [13 ]
机构：
[1] AMGEN Ltd, Ctr Observat Res, Uxbridge, Middx, England
[2] Dorset Cty Hosp, Dorchester, England
[3] Nottingham Univ Hosp, Nottingham, England
[4] Fdn IRCCS Casa Sollievo Sofferenza, Nephrol & Dialysis Unit, San Giovanni Rotondo, Italy
[5] Hosp Univ Girona, Serv Nefrol, Girona, Spain
[6] Necker Enfant Malad Hosp, Serv Nephrol Dialyse, Paris, France
[7] Catholic Univ Louvain, Clin Univ St Luc, Dept Nephrol, Brussels, Belgium
[8] Vrinnevisjukhuset, Med Kliniken, Norrkoping, Sweden
[9] Univ Hosp Leuven, Div Nephrol, Leuven, Belgium
[10] Fdn Privada Hosp Mollet, Barcelona, Spain
[11] Arbor Res Collaborat Hlth, Ann Arbor, MI USA
[12] Amgen GmbH, Rotkreuz, Switzerland
[13] UCL, Sch Pharm, London, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO524
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Criteria for calcimimetic agent in the treatment of more severe secondary hyperparathyroidism
    Pavlovic, D
    Brzac, HT
    KIDNEY INTERNATIONAL, 2001, 59 (01) : 386 - 387
  • [12] Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism
    Akizawa, Tadao
    Ikejiri, Kazuaki
    Kondo, Yuichiro
    Endo, Yuichi
    Fukagawa, Masafumi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2020, 24 (03) : 248 - 257
  • [13] Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl
    Moe, SM
    Cunningham, J
    Bommer, J
    Adler, S
    Rosansky, SJ
    Urena-Torres, P
    Albizem, MB
    Guo, MD
    Zani, VJ
    Goodman, WG
    Sprague, SM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (10) : 2186 - 2193
  • [14] AN OVERVIEW OF NURSES' MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM: HOW IS EUROPE DOING?
    de Barbieri, Ilaria
    Baumann, Jacqueline
    Casal, Maria Cruz
    Gurevich, Andrey
    Pancirova, Jitka
    Poulia, Kalliopi-Anna
    Riemann, Aase
    JOURNAL OF RENAL CARE, 2015, 41 (03) : 202 - 210
  • [15] Calcimimetic agents in the treatment of hyperparathyroidism secondary to chronic renal failure.
    Negri, AL
    Slatopolsky, EA
    MEDICINA-BUENOS AIRES, 2003, 63 (02) : 165 - 171
  • [16] Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism
    Shukla, Manojkumar R.
    Sadasivam, Gayathri
    Sarde, Ankush
    Sayyed, Majid
    Pachpute, Vipul
    Phadtare, Ramesh
    Walke, Navanath
    Chaudhari, Vinod D.
    Loriya, Rajesh
    Khan, Talha
    Gote, Ganesh
    Pawar, Chetan
    Tryambake, Mahadeo
    Mahajan, Nilesh
    Gandhe, Amruta
    Sabde, Sudeep
    Pawar, Shashikant
    Patil, Vinod
    Modi, Dipak
    Mehta, Maneesh
    Nigade, Prashant
    Modak, Vijay
    Ghodke, Ravindra
    Narasimham, Lakshmi
    Bhonde, Mandar
    Gundu, Jayasagar
    Goel, Rajan
    Shah, Chirag
    Kulkarni, Sanjeev
    Sharma, Sharad
    Bakhle, Dhananjay
    Kamboj, Rajender Kumar
    Palle, Venkata P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (14) : 9418 - 9444
  • [17] The calcimimetic AMG 073: A potential novel therapy for secondary hyperparathyroidism (SHPT).
    Block, GA
    Coyne, DW
    Goodman, WG
    Silver, MR
    Blaisdell, PW
    Olson, KA
    Turner, SA
    Lindberg, JS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 572A - 572A
  • [18] The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism
    Alfieri, Carlo
    Regalia, Anna
    Zanoni, Francesca
    Vettoretti, Simone
    Cozzolino, Mario
    Messa, Piergiorgio
    BLOOD PURIFICATION, 2019, 47 (1-3) : 37 - 44
  • [19] Etelcalcetide: injectable calcimimetic for the treatment of secondary hyperparathyroidism in hemodialysis-dependent patients
    Torres, P. A. Urena
    Bover, J.
    Cohen-Solal, M.
    DRUGS OF TODAY, 2017, 53 (09) : 489 - 500
  • [20] Calcimimetic agents and secondary hyperparathyroidism: rationale for use and results from clinical trials
    William G. Goodman
    Pediatric Nephrology, 2003, 18 : 1206 - 1210
12345